We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+12.19%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$16.9B
AUM Growth
-$1.28B
Cap. Flow
-$3.58B
Cap. Flow %
-21.13%
Top 10 Hldgs %
34.65%
Holding
323
New
13
Increased
38
Reduced
39
Closed
80

Top Buys

Rank Stock Value
1
INTU icon
Intuit
INTU
+$358M
2
CRM icon
Salesforce
CRM
+$251M
3
BABA icon
Alibaba
BABA
+$173M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$159M
5
SPGI icon
S&P Global
SPGI
+$119M

Top Sells

Rank Stock Value
1
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$497M
2
TWTR
Twitter, Inc.
TWTR
+$340M
3
ZEN
ZENDESK INC
ZEN
+$296M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$294M
5
META icon
Meta Platforms (Facebook)
META
+$245M

Sector Composition

Rank Sector Weight
1 Healthcare 32.5%
2 Technology 18.76%
3 Financials 14.5%
4 Industrials 8.33%
5 Communication Services 4.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
V icon
26
Visa
V
$677B
$259M 1.53%
1,249,010
-263,200
-17% -$53.1M
BX icon
27
Blackstone
BX
$110B
$241M 1.42%
3,248,951
+134,000
+4% +$11.6M
AON icon
28
Aon
AON
$76B
$237M 1.4%
788,086
-20,400
-3% -$5.96M
BABA icon
29
Alibaba
BABA
$308B
$234M 1.38%
2,661,000
+2,197,000
+473% +$173M
XYZ
30
Block Inc
XYZ
$47.5B
$202M 1.19%
3,218,000
+634,000
+25% +$39.1M
NYT icon
31
New York Times
NYT
$10.2B
$197M 1.16%
6,068,791
-1,759,282
-22% -$57.3M
UTHR icon
32
United Therapeutics
UTHR
$23.1B
$182M 1.08%
655,873
+106,200
+19% +$26.8M
CSGP icon
33
CoStar Group
CSGP
$12.3B
$176M 1.04%
2,280,185
-680,000
-23% -$53.1M
EXEL icon
34
Exelixis
EXEL
$13.4B
$174M 1.03%
10,868,149
+192,305
+2% +$3.14M
VMW
35
DELISTED
VMware, Inc
VMW
$171M 1.01%
1,390,623
+215,000
+18% +$24.8M
BIIB icon
36
Biogen
BIIB
$30.7B
$164M 0.97%
592,699
+287,200
+94% +$81.1M
ABBV icon
37
AbbVie
ABBV
$435B
$152M 0.9%
939,212
+214,100
+30% +$32.8M
HUM icon
38
Humana
HUM
$46.2B
$138M 0.82%
270,400
+19,200
+8% +$10.1M
BEAM icon
39
Beam Therapeutics
BEAM
$2.84B
$133M 0.79%
3,399,921
-231,350
-6% -$10.4M
CLVT icon
40
Clarivate
CLVT
$1.16B
$127M 0.75%
15,177,433
-25,368,867
-63% -$238M
SRPT icon
41
Sarepta Therapeutics
SRPT
$1.77B
$120M 0.71%
928,900
+173,950
+23% +$20.2M
SGFY
42
DELISTED
Signify Health, Inc.
SGFY
$113M 0.67%
3,950,000
+3,600,000
+1,029% +$104M
MASI
43
DELISTED
Masimo
MASI
$112M 0.66%
758,500
+181,500
+31% +$25M
LHCG
44
DELISTED
LHC Group LLC
LHCG
$111M 0.66%
689,000
+39,000
+6% +$6.44M
PCG icon
45
PG&E
PCG
$38.5B
$83.8M 0.5%
5,155,142
-1,150,000
-18% -$17.4M
BEKE icon
46
KE Holdings
BEKE
$18.8B
$80.4M 0.47%
5,758,500
-4,200,000
-42% -$58.4M
ONEM
47
DELISTED
1Life Healthcare
ONEM
$79M 0.47%
4,725,000
+1,800,000
+62% +$30.4M
CYTK icon
48
Cytokinetics
CYTK
$10.4B
$78M 0.46%
1,701,738
+80,700
+5% +$3.47M
LU icon
49
Lufax Holding
LU
$1.3B
$74.6M 0.44%
9,609,100
+4,475,000
+87% +$34.1M
ENTA icon
50
Enanta Pharmaceuticals
ENTA
$400M
$72.1M 0.43%
1,550,000
– –
1
2
3 4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Farallon Capital Management held 323 positions worth $16.9B, down 7% from $18.2B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Farallon Capital Management withdrew a net $3.58B in Q4 2022, closing 80 positions and reducing 39 holdings. Its most notable exit was Change Healthcare Inc. Common Stock, an estimated $497M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 28% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Intuit worth $351M.

  • Farallon Capital Management's largest Q4 2022 buy was Intuit: 902,100 shares worth $351M.
  • Farallon Capital Management added most to Salesforce in Q4 2022, an estimated $251M increase.
  • Farallon Capital Management's biggest Q4 2022 reduction was Clarivate, cutting an estimated $238M.
  • Farallon Capital Management fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $497M.
  • Farallon Capital Management's ten largest holdings make up 35% of its $16.9B portfolio in Q4 2022.
  • Farallon Capital Management opened 13 new positions and closed 80 in Q4 2022.
  • Farallon Capital Management's portfolio value fell 7% quarter-over-quarter to $16.9B.

Based on Farallon Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.